Live Aurobindo Pharma Share Price Chart

O 1020.6

H 1020.6

L 1020.6

VOL 9747

Aurobindo Pharma Performance

Days Range

Low: ₹1,011.15
High: ₹1,032.45
Previous Close ₹1,028.10
Open ₹1,020.60
Volume 26,89,778
Day’s Range ₹1,011.15 - ₹1,032.45
52W Range ₹444.75 - ₹1,177.10
Market Cap ₹60,202 Cr

Aurobindo Pharma Fundamentals

ROCE (TTM) 10.1
P/E Ratio (TTM) 21.73
P/B Ratio 2.14
Industry P/E 36.17
Debt to Equity 0.24
ROE 8.25
EPS (TTM) 47.97
Dividend Yield 0.73
Book Value 481.09
Face Value 1

Aurobindo Pharma Financials

Mar 2023Jun 2023Sep 2023Dec 2023
Net Sales6,472.966,850.527,219.427,351.78
Expenses5,816.356,025.716,263.486,173.74
Profit before tax730.06812.031,075.641,262.42
Operating Profit505.91569.71751.94939.97
Net Profit505.91569.71751.94939.97
EPS in Rs8.6410.9312.8316.04

About Aurobindo Pharma

History of Aurobindo Pharma Limited (APL)

Founded in 1986, Aurobindo Pharma Limited (APL) is a pharmaceutical company that is involved in the development, manufacture and sale of Active Pharma Ingredients (API) and formulations.

The company started their operations in 1988-1989 with a single manufacturing unit at Pondicherry to manufacture Semi Synthetic Penicillins (SSPs).  Between 1992-1993, they set up another manufacturing facility in Hyderabad to manufacture CMIC Chloride, a bulk drug intermediate. In 1994, the company merged with Chaitanya Organics Pvt. Ltd and started the commercial production of the pharmaceutical formulation unit. In 1995, Aurobindo Pharma Limited went public. Since then, the company has expanded its product base and started manufacturing various formulations.

From  2003 to 2004, the company set up a subsidiary in China and started commercial production. Between 2005 to 2006, Aurobindo Pharma Limited acquired UK-based Milpharm Limited, which is involved in marketing generic formulations in the UK market. They established their presence worldwide in Brazil, the USA, Puerto Rico and Portugal.

As of March 2023, Aurobindo Pharma Limited has 25 State-of-the-art manufacturing and packaging facilities, with export presence in more than 150 countries, 9 R&D centres and over 1,500 scientists and analysts involved in R&D activities.

Business Segments of Aurobindo Pharma Limited 

  • API: Under this segment, Aurobindo Pharma Limited develops and manufactures APIs. Their five manufacturing units are inspected and approved by the US FDA, ANVISA, TGA Australia, UK MHRA and other trusted regulatory agencies.
  • Antiretroviral (ARV): Under this, the company works with an aim to offer a wide range of high-quality antiretroviral drugs (US FDA Approved) for PLHIV & CLHIV.
  • AuroZymes: This is the biocatalysts division of APL that develops and produces biocatalysts that can be utilised in the Chemical and Pharmaceutical Industries.
  • Custom Synthesis: In this segment, the company provides customer-centric project-based chemistry services through their custom research and manufacturing division, AuroSource.
  • Formulations: Under this segment, APL is involved in cost-effective drug development and substantial manufacturing.
  • Peptides: In this segment, the company develops peptide-based generic APIs, specifically focusing on diabetology and oncology segments.
  • R&D: The R&D segment of the company is involved in developing new drug delivery systems and new dosage formulations.

As of March 31, 2023, some of the subsidiaries of Aurobindo Pharma Limited are as follows:

  • Helix Healthcare B.V.: This subsidiary of the company is involved in the healthcare sector.
  • Aurovitas Pharma Polska: This is a wholly-owned subsidiary of the company that focuses on generic, Rx and OTC drugs covering 22 therapeutic areas.
  • Milpharm Limited: This wholly-owned subsidiary of the company that manufactures pharma products.

Key Personalities of Aurobindo Pharma Limited

Nityananda Reddy, Managing Director and Chairman

Nityananda Reddy is the Chairman and Managing Director of Aurobindo Pharma Limited. He has been associated with APL since its initial days. He has experience in manufacturing technology and oversees the overall affairs of the company.

Corporate Actions of Aurobindo Pharma Limited

The company issued a bonus share of a 1:1 ratio with a record date of July 21, 2015.

Parent Organisation Indian Private
Founded 1986
Managing Director K Ragunathan
NSE Symbol AUROPHARMA

Peer Comparison

Stocks Market Cap (cr) Market Price (₹) 52 Week Low-High (₹)
Ajanta Pharma Ltd ₹27,758.33

2130

78.00 (-3.53%)

2110.1 - 2220.3
Lupin Ltd ₹73,756.88

1624.55

3.50 (0.22%)

1618 - 1637.75
Gland Pharma Ltd ₹29,065.22

1780

14.05 (0.80%)

1740.45 - 1807
Syngene International Ltd ₹28,398.34

705.95

0.10 (-0.01%)

701.25 - 711
Alkem Laboratories Ltd ₹61,250.16

5115

12.35 (-0.24%)

5103.05 - 5168.95

What's Trending

Aurobindo Pharma FAQs

What is the Share price of Aurobindo Pharma (AUROPHARMA)?

Aurobindo Pharma (AUROPHARMA) share price as of March 1, 2024, on NSE is Rs 1,026.85 (NSE) and Rs 1,027.30 (BSE) on BSE.

Can I buy Aurobindo Pharma (AUROPHARMA) shares?

Yes, You can buy Aurobindo Pharma (AUROPHARMA) shares by opening a Demat account with Angel One.

How do I buy Aurobindo Pharma (AUROPHARMA) from Angel One?

Aurobindo Pharma (AUROPHARMA) share can be brought through the following modes:
  1. Direct investment: You can buy Aurobindo Pharma (AUROPHARMA) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Aurobindo Pharma (AUROPHARMA) shares.

Is Aurobindo Pharma a Debt free Company?

No, Aurobindo Pharma is not a debt free company.

What is the main business of Aurobindo Pharma?

The main business of Aurobindo Pharma is to manufacture semi-synthetic penicillin (SSP) through over 27 manufacturing and packaging facilities situated globally. It also has a presence in several therapeutic segments, including neurosciences, gastroenterology, cardiovascular, anti-diabetics, anti-retrovirals, and anti-biotics

Who are the promoters of Aurobindo Pharma?

Some of the promoters of Aurobindo Pharma include Rpr Sons Advisors Private Limited, Mrs.P.Suneela Rani (Jointly Holding), K Nityananda Reddy, Kirthi Reddy Kambam, Venkata Ramprasad Reddy Penaka, and Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd (Jointly Holding).

What are the Subsidiaries that comes under Aurobindo Pharma?

Some of the subsidiaries that come under Aurobindo Pharma are APL Pharma Thai Limited, All Pharma (Shanghai) Trading Company Limited, Aurobindo Pharma USA Inc., Aurobindo Pharma Industria Farmaceutica Ltda, Brazil, Helix Healthcare B.V., The Netherlands, Auro Pharma Inc., Canada, and APL Healthcare Limited.